Solubility of α-synuclein species in the L62 mouse model of synucleinopathy by Karima Schwab, Mandy Magbagbeolu, Franz Theuring, Charles R. Harrington, Claude M. Wischik, Gernot Riedel

Get full text

Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks by Karima Schwab, Valeria Melis, Charles R. Harrington, Claude M. Wischik, Mandy Magbagbeolu, Franz Theuring, Gernot Riedel

Get full text

Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease by Lewis K. Penny, Richard Lofthouse, Mohammad Arastoo, Andy Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik

Get full text

Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391) by Youssra K. Al-Hilaly, Youssra K. Al-Hilaly, Connor Hurt, Janet E. Rickard, Charles R. Harrington, Charles R. Harrington, John M. D. Storey, John M. D. Storey, Claude M. Wischik, Claude M. Wischik, Louise C. Serpell, Ansgar B. Siemer

Get full text

Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model by Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R. Harrington, Claude M. Wischik, Gernot Riedel, Grazyna Niewiadomska

Get full text

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates by Mahmoud B. Maina, Youssra K. Al-Hilaly, Gunasekhar Burra, Janet E. Rickard, Charles R. Harrington, Claude M. Wischik, Louise C. Serpell

Get full text

Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia by Karima Schwab, Lianne Robinson, Anne Annschuetz, Eline Dreesen, Mandy Magbagbeolu, Valeria Melis, Franz Theuring, Charles R. Harrington, Claude M. Wischik, Gernot Riedel

Get full text

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis by Alex Zabala-Findlay, Lewis K. Penny, Richard A. Lofthouse, Andrew J. Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik, Mohammad Arastoo

Get full text

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors by Karima Schwab, Dilyara Lauer, Mandy Magbagbeolu, Franz Theuring, Anna Gasiorowska, Maciej Zadrozny, Charles R. Harrington, Claude M. Wischik, Grażyna Niewiadomska, Gernot Riedel

Get full text

HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine by Renato X. Santos, Valeria Melis, Elizabeth A. Goatman, Michael Leith, Thomas C. Baddeley, John M. D. Storey, Gernot Riedel, Claude M. Wischik, Charles R. Harrington

Get full text

High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer’s disease by Mohammad Arastoo, Lewis K. Penny, Richard Lofthouse, Aya Abdallah, Anna Abrahamsson, Pietro Marini, Valeria Melis, Gernot Riedel, Charles R. Harrington, Claude M. Wischik, Andrew Porter, Soumya Palliyil

Get full text

Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe by Elizabeta B. Mukaetova-Ladinska, John H. Xuereb, Francisco Garcia-Sierra, Jenny Hurt, Herman-J. Gertz, Richard Hills, Carol Brayne, Felicia A. Huppert, Eugene S. Paykel, Magnus A. McGee, Ross Jakes, William G. Honer, Charles R. Harrington, Claude M. Wischik, CC75C Collaboration Group

Get full text